| abstract |
PROBLEM TO BE SOLVED: There is a continuing need for compositions and methods for improving negatively affected cell function due to one or more mechanisms associated with cellular senescence. A pharmaceutical formulation comprising an exosome derived from mobilized stem cells and one or more pharmaceutically acceptable carriers, adjuvants, or vehicles. A pharmaceutical formulation comprising microvesicles derived from mobilized stem cells and one or more pharmaceutically acceptable carriers, adjuvants, or vehicles. A pharmaceutical formulation comprising an exosome-derived and / or microvesicle-derived molecule and one or more pharmaceutically acceptable carriers, adjuvants, or vehicles. |